share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer BOURLA ALBERT

SEC announcement ·  Jun 4 17:08
Summary by Moomoo AI
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
Pfizer Inc. (PFE) Chairman & CEO Albert Bourla executed a transaction of non-derivative securities on May 31, 2024. The specific details of the transaction, including the number of shares, transaction price, and total value, have not been disclosed in the provided announcement. The action reflects a change in Bourla's holdings in the company, but without additional information, the impact on his total number of shares held after the action cannot be determined.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more